Stromal cell-derived factor-1/CXCL12 directly enhances survival/antiapoptosis of myeloid progenitor cells through CXCR4 and Gαi proteins and enhances engraftment of competitive, repopulating stem cells-Reference-Cited by-同舟云学术

Stromal cell-derived factor-1/CXCL12 directly enhances survival/antiapoptosis of myeloid progenitor cells through CXCR4 and Gαi proteins and enhances engraftment of competitive, repopulating stem cells

Published:2003-05 Issue:5 Volume:73 Page:630-638
ISSN:0741-5400
Container-title:Journal of Leukocyte Biology
language:en
Short-container-title:Journal of Leukocyte Biology

Author:

Broxmeyer Hal E.,Kohli Lisa,Kim Chang H.,Lee Younghee,Mantel Charlie,Cooper Scott,Hangoc Giao,Shaheen Montaser,Li Xiaxin,Clapp D. Wade

Funder

U.S. Public Health Service

National Institutes of Health

Publisher

Wiley

Subject

Cell Biology,Immunology,Immunology and Allergy

Reference56 articles.

1. Apoptosis in development;Meier;Nature,2000

2. CD95's deadly mission in the immune system;Krammer;Nature,2000

3. Resistance of t(4;11) (MLL-AF4 fusion gene) leukemias to stress-induced cell death: possible mechanism for extensive extramedullary accumulation of cells and poor prognosis;Kersey;Leukemia,1998

4. MLL rearrangements in haematological malignancies: lessons from clinical and biological studies;DiMartino;Br. J. Haematol.,1999

5. From bench to clinic with apoptosis-based therapeutic agents;Nicholson;Nature,2000

Cited by 169 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Allosteric modulation of the CXCR4:CXCL12 axis by targeting receptor nanoclustering via the TMV-TMVI domain;eLife;2024-09-09

2. Allosteric modulation of the CXCR4:CXCL12 axis by targeting receptor nanoclustering via the TMV-TMVI domain;eLife;2024-09-09

3. Allosteric modulation of the CXCR4:CXCL12 axis by targeting receptor nanoclustering via the TMV-TMVI domain;2024-08-14

4. Allosteric modulation of the CXCR4:CXCL12 axis by targeting receptor nanoclustering via the TMV-TMVI domain;2024-02-14

5. Allosteric modulation of the CXCR4:CXCL12 axis by targeting receptor nanoclustering via the TMV-TMVI domain;2023-11-21